Oral isobutyramide therapy in patients with thalassemia intermedia: Results of a phase II open study

Blood Cells, Molecules, and Diseases

Volumn 26, Issue 1, 2000, Pages 105-111

  Cappelinni, Maria Domenica ^a   Graziadei, Giovanna ^a   Ciceri, Laura ^a   Comino, Alessia ^a   Bianchi, Paolo ^a   Porcella, Antonella ^a   Fiorelli, Gemino ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Butyrates; Hb switch; Hb F induction; Isobutyramide; Thalassemia

Indexed keywords

BUTYRIC ACID DERIVATIVE; HEMOGLOBIN F; ISOBUTYRAMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMOGLOBIN SYNTHESIS; HUMAN; MALE; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THALASSEMIA;

EID: 0034143867     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2000.0283     Document Type: Article

References (30)

1. Olivieri N F, Nathan D G, MacMillan J H. N Engl J Med. 331:1994;574-578.
2. Olivieri N F. N Engl J Med. 341:1999;99-109.
3. Cappellini M D, Fiorelli G., Bernini C F. Br J Haematol. 48:1981;561-572.
4. Thein S L, Wood W G, Wckramasinghe S N, Galvin M C. Blood. 82:1993;961-967.
5. Nienhuis A W, Ley T J, Humphries R K, Young N S, Dover G. Ann NY Acad Sci. 445:1985;198-211.
6. Stamatoyannopoulos J A, Nienhuis A W. Annu Rev Med. 43:1992;497-521.
7. Perrine S., Faller D V. Experientia. 49:1993;133-137.
8. Rodgers G P, Rachmilewitz E A. Br J Haematol. 91:1995;263-268.
9. Ginder G D, Witters M J, Pohlman J K. Proc Natl Acad Sci USA. 81:1984;3954-3958.
10. Perrine S P, Rudolph A., Faller D V. Proc Natl Acad Sci USA. 85:1988;8540-8542.
11. Perrine S P, Miller B A, Faller D V. Blood. 74:1989;454-459.
12. Glauber J G, Wandersee N J, Little J A, Ginder G D. Mol Cell Biol. 11:1991;4690-4697.
13. Fibach E., Prasanna P., Rodgers G P, Samid D. Blood. 82:1993;2203-2206.
14. Stamatoyannopoulos G., Blau C A, Nakamoto B. Blood. 84:1994;3198-3204.
15. Pace B., Li Q., Peterson K., Stamatoyannopoulos G. Blood. 84:1994;4344-4353.
16. Blau C A, Constantoulakis P., Shaw C M, Stamatoyannopoulos G. Blood. 81:1993;529-537.
17. Liakopoulou E., Blau C A, Li Q. Blood. 86:1995;3227-3235.
18. Liakopoulou, E, Blau, C, A, Stamatoyannopoulos, G. Induction of fetal hemoglobin by short chain fatty acids. In: Stamatoyannopoulos, G., ed. Molecular Biology of Hemoglobin Switching. Andover, Intercept, pp. 333-338, 1995.
19. Perrine S P, Ginder G., Faller D V. N Engl J Med. 328:1993;81-86.
20. Sher G D, Ginder G D, Little J., Yang S., Dover G J, Olivieri N F. N Engl J Med. 24:1995;1606-1610.
21. Collins A F, Pearson H A, Giardina P., McDonagh K T, Brusilow S W, Dover G J. Blood. 85:1995;43-49.
22. Dover G J, Brusilow S., Charache S. Blood. 84:1994;339-343.
23. Atweh G F, Sutton M., Nassif I. Blood. 93:1999;1790-1797.
24. Riggs M G, Wittaker R G, Neumann J R, Ingramm V M. Nature. 268:1977;462.
25. Perrine S P, Dover G H, Daftari P. Br J Haematol. 88:1994;555-561.
26. Brettman L R, Chaturvedi P R. J Clin Pharmacol. 36:1996;617-622.
27. Camaschella C., Mazza U., Roetto A. Am J Hematol. 48:1995;82-87.
28. Miller A B, Hoogstraten B., Staquet M., Winkler A. Cancer. 47:1981;207-214.
29. Zago M A, Wood W G, Clegg B J, Weatherall D J, O'Sullivan M., Gunson H. Blood. 53:1979;977-986.
30. Turner B M. J Cell Sci. 99:1991;13-20.